Details:

Alternative Title:
Emerg Infect Dis
Personal Author:
Engberg, J. ; Aarestrup, F. M. ; Taylor, D. E. ; Gerner-Smidt, P. ; Nachamkin, I.
Engberg, J. ; Aarestrup, F. M. ; Taylor, D. E. ; Gerner-Smidt, P. ; Nachamkin, I. Less -
Description:
The incidence of human Campylobacter jejuni and C. coli infections has increased markedly in many parts of the world in the last decade as has the number of quinolone-resistant and, to a lesser extent, macrolide-resistant Campylobacter strains causing infections. We review macrolide and quinolone resistance in Campylobacter and track resistance trends in human clinical isolates in relation to use of these agents in food animals. Susceptibility data suggest that erythromycin and other macrolides should remain the drugs of choice in most regions, with systematic surveillance and control measures maintained, but fluoroquinolones may now be of limited use in the empiric treatment of Campylobacter infections in many regions.
Subject:
[+]
Animal Diseases
Animals
Anti-Bacterial Agents
Anti-Infective Agents
Campylobacter Coli
Campylobacter Jejuni
Drug Resistance, Microbial
Drug Resistance, Multiple
Fluoroquinolones
Humans
Macrolides
Time Factors

Source:
Emerg Infect Dis. 7(1):24-34.
Document Type:
Journal Article
Collection(s):
Emerging Infectious Diseases
Main Document Checksum:
[+]
urn:sha256:6c41ced077ec58e15944a40829259cb0b711db82e91f625dc538813ad5ddd1ee
File Type:

Supporting Files

• 	11266291.nxml	txt
  	license.txt	txt

More +